Cargando…

Pharmacogenomic‐based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system

Pharmacogenomics (PGx)‐based personalized medicine (PM) is increasingly utilized to guide treatment decisions for many drug‐disease combinations. Notably, London Health Sciences Centre (LHSC) has pioneered a PGx program that has become a staple for London‐based specialists. Although implementational...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subasri, Mathushan, Barrett, David, Sibalija, Jovana, Bitacola, Lisa, Kim, Richard B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604218/ https://www.ncbi.nlm.nih.gov/pubmed/34080317 http://dx.doi.org/10.1111/cts.13083

Ejemplares similares

Assessing the Educational and Supportive Care Needs of Canadian Metastatic Melanoma Patients and Survivors Attending an Outpatient Clinic
por: Subasri, Mathushan, et al.
Publicado: (2021)

Multistakeholder perspectives on the mistreatment of indigenous women during childbirth in Colombia: drivers and points for intervention
por: Gleason, Emily Gaffney, et al.
Publicado: (2022)

Barriers and Facilitators to Resuming In-Person Psychotherapy with Perinatal Patients amid the COVID-19 Pandemic: A Multistakeholder Perspective
por: Andrejek, Nicole, et al.
Publicado: (2021)

Future of the drug label: Perspectives from a multistakeholder dialogue
por: Gispen‐de Wied, Christine C., et al.
Publicado: (2019)

Left atrial appendage aneurysm in pediatrics: Case study and literature review
por: Norozi, Kambiz, et al.
Publicado: (2023)

Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare
por: Giri, Jyothsna, et al.
Publicado: (2019)

Multistakeholder Perspectives on Maternal Text Messaging Intervention in Uganda: Qualitative Study
por: Ilozumba, Onaedo, et al.
Publicado: (2018)

THE IMPACT OF THE COVID-19 PANDEMIC ON DEMENTIA CARE: A MULTISTAKEHOLDER PERSPECTIVE
por: Masoud, Sara, et al.
Publicado: (2022)

A critical analysis of barriers to the clinical implementation of pharmacogenomics
por: McKinnon, Ross A, et al.
Publicado: (2007)

Analysis of TERT Isoforms across TCGA, GTEx and CCLE Datasets
por: Subasri, Mathushan, et al.
Publicado: (2021)

Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective
por: Stephenson, Diane, et al.
Publicado: (2021)

Examining the use of the FIGO Nutrition Checklist in routine antenatal practice: multistakeholder feedback to implementation
por: Killeen, Sarah Louise, et al.
Publicado: (2020)

Examining Intersectoral Action as an Approach to Implementing Multistakeholder Collaborations to Achieve the Sustainable Development Goals
por: Trowbridge, Joslyn, et al.
Publicado: (2022)

Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical Practice
por: Lam, Y. W. Francis
Publicado: (2013)

Integration of Traditional Birth Attendants into Mental Healthcare: A Multistakeholder Qualitative Study Exploration
por: Musyimi, Christine W., et al.
Publicado: (2019)

“Handing out non-prescribed antibiotics is storing up trouble for the next generation!” Unpacking multistakeholder views of drivers and potential solutions in Ethiopia
por: Belachew, Sewunet Admasu, et al.
Publicado: (2023)

Implementing Psychological Interventions Through Nonspecialist Providers and Telemedicine in High-Income Countries: Qualitative Study from a Multistakeholder Perspective
por: Singla, Daisy Radha, et al.
Publicado: (2020)

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
por: Patel, Jai N
Publicado: (2016)

A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)

What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective
por: Howard, Sam, et al.
Publicado: (2016)

Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program
por: Melendez, Karina, et al.
Publicado: (2023)

Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)

Transnational multistakeholder partnerships for sustainable development: Conditions for success
por: Pattberg, Philipp, et al.
Publicado: (2015)

Multistakeholder perspectives on the strengthening and embedding of mandatory continuing medical education in Georgia: a qualitative study
por: Ruadze, Ekaterine, et al.
Publicado: (2021)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
por: Van Heukelom, Joel, et al.
Publicado: (2023)

Survey of physicians' views on the clinical implementation of pharmacogenomics-based personalized therapy
por: Kim, Woo-Young, et al.
Publicado: (2020)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications
por: Tanner, Julie-Anne, et al.
Publicado: (2019)

Multistakeholder Participation in Disaster Management—The Case of the COVID-19 Pandemic
por: Panneer, Sigamani, et al.
Publicado: (2021)

Let’s Join Forces: Institutional Resilience and Multistakeholder Partnerships in Crises
por: Krlev, Gorgi
Publicado: (2022)

A review on individual and multistakeholder fairness in tourism recommender systems
por: Banerjee, Ashmi, et al.
Publicado: (2023)

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)

Pharmacogenomics: the promise of personalized medicine.
por: Hood, Ernie
Publicado: (2003)

5. Pharmacogenomics and Personalized Medicine
por: Topić, Elizabeta
Publicado: (2008)

Engaging Multistakeholder Perspectives to Identify Patient‐Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions
por: Venkatachalam, Shilpa, et al.
Publicado: (2023)

Paving the way for solutions improving access to kidney transplantation: a qualitative study from a multistakeholder perspective
por: van Merweland, Ruben, et al.
Publicado: (2023)

Barriers and facilitators to the implementation of person‐centred care in different healthcare contexts
por: Moore, Lucy, et al.
Publicado: (2016)

Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices
por: Luke, Miles J., et al.
Publicado: (2021)

Multistakeholder Engagement in PCORnet, the National Patient-Centered Clinical Research Network
por: Selby, Joe V., et al.
Publicado: (2018)

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ec38soude26nid5kmiq4tm4kgn